Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 1/20 | 0.57 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Melibiose SCHEMBL4257775 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL20421903 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356838 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| SCHEMBL18650670 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL109659 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL24013212 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21114348 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356841 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356840 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL1782423 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9028890-B2 | Composition for improving sexual wellness | HORPHAG RESEARCH (IP) PRE LTD. (CY) | 2015-05-12 | — | — | US | disclosed |
| EP-2585088-B1 | COMPOSITION FOR IMPROVING SEXUAL WELLNESS | HORPHAG RES IP PRE LTD (CY) | 2014-06-18 | — | — | EP | disclosed |
| US-20130164394-A1 | COMPOSITION FOR IMPROVING SEXUAL WELLNESS | HORPHAG RESEARCH (IP) PRE LTD. (CY) | 2013-06-27 | — | — | US | disclosed |
| US-20110257110-A1 | Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition | HYBEN VITAL LICENS APS (DK) | 2011-10-20 | — | — | US | disclosed |
| EP-2041151-B1 | A METHOD OF PREPARING A GLYCOSIDE OF A MONO- OR DIACYLGLYCEROL PRODUCT FROM A PLANT MATERIAL | HYBEN VITAL LICENS APS (DK) | 2011-09-14 | — | — | EP | disclosed |
| EP-2349281-A1 | COMPOSITION COMPRISING A GLYCOSIDE OF A MONO- OR DIACYIGLYCEROL COMPOUND AND AN OIL RICH IN N-3 POLYUNSATURATED FATTY ACIDS, A METHOD OF PRODUCING THE COMPOSITION AND USE OF THE COMPOSITION | Hyben Vital Licens ApS (DK) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010048955-A1 | COMPOSITION COMPRISING A GLYCOSIDE OF A MONO- OR DIACYIGLYCEROL COMPOUND AND AN OIL RICH IN N-3 POLYUNSATURATED FATTY ACIDS, A METHOD OF PRODUCING THE COMPOSITION AND USE OF THE COMPOSITION | HYBEN VITAL LICENS APS (DK) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164394-A1 | COMPOSITION FOR IMPROVING SEXUAL WELLNESS | KISS1R, ARGLU1, ARG2 | GAA 3105/4885CA2 3650/4885CDK1 4479/4885 |
| US-20110257110-A1 | Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition | DGKG, DGKK, DGKA | GAA 1943/4885CA2 2807/4885CDK1 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.